79 related articles for article (PubMed ID: 16848769)
1. Natural killer T cells and haemopoiesis.
Karadimitris A; Patterson S; Spanoudakis E
Br J Haematol; 2006 Aug; 134(3):263-72. PubMed ID: 16848769
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of CD1d-restricted invariant natural killer T cell-based treatment for autoimmune diseases.
Miyake S; Yamamura T
Int Rev Immunol; 2007; 26(1-2):73-94. PubMed ID: 17454265
[TBL] [Abstract][Full Text] [Related]
3. The in vivo response of invariant natural killer T cells to glycolipid antigens.
Parekh VV; Lalani S; Van Kaer L
Int Rev Immunol; 2007; 26(1-2):31-48. PubMed ID: 17454263
[TBL] [Abstract][Full Text] [Related]
4. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
Wu L; Gabriel CL; Parekh VV; Van Kaer L
Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
[TBL] [Abstract][Full Text] [Related]
5. CD1d-restricted glycolipid antigens: presentation principles, recognition logic and functional consequences.
Florence WC; Bhat RK; Joyce S
Expert Rev Mol Med; 2008 Jul; 10():e20. PubMed ID: 18601810
[TBL] [Abstract][Full Text] [Related]
6. Invariant natural killer T cells and immunotherapy of cancer.
Molling JW; Moreno M; van der Vliet HJ; van den Eertwegh AJ; Scheper RJ; von Blomberg BM; Bontkes HJ
Clin Immunol; 2008 Nov; 129(2):182-94. PubMed ID: 18783990
[TBL] [Abstract][Full Text] [Related]
7. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.
Mallevaey T; Fontaine J; Breuilh L; Paget C; Castro-Keller A; Vendeville C; Capron M; Leite-de-Moraes M; Trottein F; Faveeuw C
Infect Immun; 2007 May; 75(5):2171-80. PubMed ID: 17353286
[TBL] [Abstract][Full Text] [Related]
8. beta-Glycosphingolipids as immune modulators.
Adar T; Ilan Y
J Immunotoxicol; 2008 Apr; 5(2):209-20. PubMed ID: 18569392
[TBL] [Abstract][Full Text] [Related]
9. Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity.
Wilson SB; Delovitch TL
Nat Rev Immunol; 2003 Mar; 3(3):211-22. PubMed ID: 12658269
[TBL] [Abstract][Full Text] [Related]
10. Role of NKT cells in the digestive system. III. Role of NKT cells in intestinal immunity.
Zeissig S; Kaser A; Dougan SK; Nieuwenhuis EE; Blumberg RS
Am J Physiol Gastrointest Liver Physiol; 2007 Dec; 293(6):G1101-5. PubMed ID: 17717040
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells.
Liu YP; Li Z; Nador RG; Strober S
Transplantation; 2008 Feb; 85(4):607-14. PubMed ID: 18347541
[TBL] [Abstract][Full Text] [Related]
12. Understanding the behavior of invariant NKT cells in autoimmune diseases.
Yamamura T; Sakuishi K; Illés Z; Miyake S
J Neuroimmunol; 2007 Nov; 191(1-2):8-15. PubMed ID: 17905445
[TBL] [Abstract][Full Text] [Related]
13. Aging is associated with a rapid decline in frequency, alterations in subset composition, and enhanced Th2 response in CD1d-restricted NKT cells from human peripheral blood.
Jing Y; Gravenstein S; Chaganty NR; Chen N; Lyerly KH; Joyce S; Deng Y
Exp Gerontol; 2007 Aug; 42(8):719-32. PubMed ID: 17368996
[TBL] [Abstract][Full Text] [Related]
14. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids.
Paget C; Mallevaey T; Speak AO; Torres D; Fontaine J; Sheehan KC; Capron M; Ryffel B; Faveeuw C; Leite de Moraes M; Platt F; Trottein F
Immunity; 2007 Oct; 27(4):597-609. PubMed ID: 17950005
[TBL] [Abstract][Full Text] [Related]
15. Innate immunity modulates autoimmunity: type 1 interferon-beta treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation.
Gigli G; Caielli S; Cutuli D; Falcone M
Immunology; 2007 Nov; 122(3):409-17. PubMed ID: 17617156
[TBL] [Abstract][Full Text] [Related]
16. Co-inhibitory roles for glucocorticoid-induced TNF receptor in CD1d-dependent natural killer T cells.
Chen S; Ndhlovu LC; Takahashi T; Takeda K; Ikarashi Y; Kikuchi T; Murata K; Pandolfi PP; Riccardi C; Ono M; Sugamura K; Ishii N
Eur J Immunol; 2008 Aug; 38(8):2229-40. PubMed ID: 18624295
[TBL] [Abstract][Full Text] [Related]
17. Progress in acute graft versus host disease.
Holler E
Curr Opin Hematol; 2007 Nov; 14(6):625-31. PubMed ID: 17898566
[TBL] [Abstract][Full Text] [Related]
18. Methods for detection, isolation and culture of mouse and human invariant NKT cells.
Watarai H; Nakagawa R; Omori-Miyake M; Dashtsoodol N; Taniguchi M
Nat Protoc; 2008; 3(1):70-8. PubMed ID: 18193023
[TBL] [Abstract][Full Text] [Related]
19. Interactions between B-lymphocytes and type 1 NKT cells in autoimmune diabetes.
Dufour FD; Silveira PA; Baxter AG
J Immunotoxicol; 2008 Apr; 5(2):249-57. PubMed ID: 18569396
[TBL] [Abstract][Full Text] [Related]
20. NKT cells: T lymphocytes with innate effector functions.
Van Kaer L
Curr Opin Immunol; 2007 Jun; 19(3):354-64. PubMed ID: 17428648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
